
Valitse etikettisi
näkyy suoraan injektiopullossaLaboratorioraportti
PDF- Testattu
- Letrozol (Femara) 2.5mg × 100 Tabs
- Laboratorio
- Analiza Białek
- Päivämäärä
- October 2026
- Tulos
- 2.72 mg per tablet (2.5 mg label)
- Tilauksen nro
- Salasana
Testattu riippumattomasti, tarkistettavissa salasanalla suoraan laboratoriossa.
Letrozol (Femara)
PCT & AI
- Laboratoriotestattu
- Lähetetään Saksasta
Tilaus
- DHL seurannalla
- Huomaamaton pakkaus
Yhdellä silmäyksellä
Letrozol (Femara) lukuina
Tietopankkimme keskeiset luvut. Vedä pistettä käyrää pitkin nähdäksesi, paljonko yhden annoksen jälkeen on laskennallisesti jäljellä.
Koko tietopankkiartikkeliHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~3 days
Simplified model without an absorption phase, half-life from the TPD lexicon. The lexicon gives 2 to 4 days, we calculate with the middle.
Half-life
about2-4days
- Class
- Aromatase inhibitornon-steroidal, reversible
- Use
- Oral1-2x per week
- Sizes
- 2.5 mg2 sizes in the shop
What studies show
All 2 sources in the lexiconLetrozole vs tamoxifen in postmenopausal breast cancer (BIG 1-98) (opens in a new tab)
BIG 1-98 Collaborative Group, NEJM, 2005- over99 %Geisler et al., Journal of Clinical Oncology, 2002
Arvostelut
Mitä asiakkaat sanovat
Vain todelliset tilaukset, joissa oli Letrozol (Femara).
Kaikki arvostelutTietoa
Kaikki aiheesta Letrozol (Femara)
Tarkemmat tiedot tulossa pian.
Is letrozole approved?
Yes. In the USA letrozole has been approved as a prescription tablet since 25 July 1997 and ChEMBL lists phase 4 as the highest phase. The large studies concern breast cancer after menopause.
How much does letrozole lower estrogens?
In a study with 12 women who took both drugs one after the other, letrozole suppressed whole-body estrogen production by more than 99.1 percent and anastrozole by 97.3 percent. Estradiol in the blood fell by 87.8 percent with letrozole and estrone sulfate by 98.0 percent.
What did BIG 1-98 show?
Over 8,000 postmenopausal women with hormone-sensitive breast cancer received letrozole or tamoxifen. After five years an estimated 84.0 against 81.4 percent were free of recurrence and the risk of recurrence fell by 19 percent. In return skeletal and cardiac events as well as raised cholesterol were more common with letrozole.
What is known in PCOS?
In a study of 750 women with PCOS trying to conceive letrozole led to a live birth more often than clomiphene (27.5 against 19.1 percent) and to ovulation more often. Hot flushes were more common with clomiphene, fatigue and dizziness with letrozole.
What about bone and blood lipids?
Less estrogen means less protection for bone. In MA.17 5.8 percent on letrozole and 4.5 percent on placebo received a new osteoporosis diagnosis, the difference was not significant. In BIG 1-98 raised cholesterol was more common with letrozole.
How long does letrozole stay in the body?
The US label gives a terminal elimination half-life of about 2 days. According to the label a steady level is only reached after 2 to 6 weeks of daily use.
Vertailut
Miten se vertautuu
Liittyvät
Samankaltaiset tuotteet
Clomid (Clomifen)
Lääkkeet · Post-cycle ja aromataasin estäjät Post-cycle ja aromataasin estäjät
2 kokoa
Tamoxifen (Nolvadex)
Lääkkeet · Post-cycle ja aromataasin estäjät Post-cycle ja aromataasin estäjät
2 kokoa
Laboratoriotestattu
Aromasin (Exemestane)
Lääkkeet · Post-cycle ja aromataasin estäjät Post-cycle ja aromataasin estäjät
2 kokoa
Arimidex (Anastrozole)
Lääkkeet · Post-cycle ja aromataasin estäjät Post-cycle ja aromataasin estäjät
2 kokoa
Letrozol (Femara)
